NCT01919710View on ClinicalTrials.gov

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Underdose (Unintentional)CancerTumor
Interventions
DRUG

rHSA/GCSF

for treatment of neutropenia

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Tianjin SinoBiotech Ltd.

INDUSTRY

NCT01919710 - Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia | Biotech Hunter | Biotech Hunter